Triple

T19331799
Position Surface form Disambiguated ID Type / Status
Subject Fosun Pharma E483513 entity
Predicate hasSubsidiary P254 FINISHED
Object Chongqing Yaoyou Pharmaceutical NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Chongqing Yaoyou Pharmaceutical | Statement: [Fosun Pharma, hasSubsidiary, Chongqing Yaoyou Pharmaceutical]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Chongqing Yaoyou Pharmaceutical
Context triple: [Fosun Pharma, hasSubsidiary, Chongqing Yaoyou Pharmaceutical]
  • A. Zhongyuan Guanhua
    Zhongyuan Guanhua is a major dialect group of Mandarin Chinese spoken primarily in China’s Central Plains region, including parts of Henan, Shanxi, Shaanxi, and surrounding areas.
  • B. Shanghai Jiushi Group
    Shanghai Jiushi Group is a major state-owned enterprise in Shanghai involved in urban infrastructure, transportation, and sports and cultural event operations.
  • C. Jianghuai Guanhua
    Jianghuai Guanhua is a major variety of Mandarin Chinese spoken primarily in parts of Jiangsu and Anhui provinces, characterized by distinctive phonological and lexical features.
  • D. Zhonghe Dian
    Zhonghe Dian is a ceremonial hall within Beijing’s Forbidden City, historically used by the emperor for preparations and brief audiences before major imperial rituals.
  • E. Zhongxun
    Zhongxun is the given name of Xi Zhongxun, a prominent Chinese Communist revolutionary and senior political leader.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Chongqing Yaoyou Pharmaceutical
Target entity description: Chongqing Yaoyou Pharmaceutical is a Chinese pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines and related healthcare products.
  • A. Zhongyuan Guanhua
    Zhongyuan Guanhua is a major dialect group of Mandarin Chinese spoken primarily in China’s Central Plains region, including parts of Henan, Shanxi, Shaanxi, and surrounding areas.
  • B. Shanghai Jiushi Group
    Shanghai Jiushi Group is a major state-owned enterprise in Shanghai involved in urban infrastructure, transportation, and sports and cultural event operations.
  • C. Jianghuai Guanhua
    Jianghuai Guanhua is a major variety of Mandarin Chinese spoken primarily in parts of Jiangsu and Anhui provinces, characterized by distinctive phonological and lexical features.
  • D. Zhonghe Dian
    Zhonghe Dian is a ceremonial hall within Beijing’s Forbidden City, historically used by the emperor for preparations and brief audiences before major imperial rituals.
  • E. Zhongxun
    Zhongxun is the given name of Xi Zhongxun, a prominent Chinese Communist revolutionary and senior political leader.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8e8d13e3c81909d91d1d5ec37c095 completed April 10, 2026, 12:10 p.m.
NER Named-entity recognition batch_69e616422fa08190bf4bde4312ec7cf3 completed April 20, 2026, 12:04 p.m.
Created at: April 10, 2026, 1:33 p.m.